Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Dec;101(8):891-895.
doi: 10.1111/aos.15801.

The roadmap to geographic atrophy treatment: A journey of trials and promise

Omer Trivizki  1   2 , Anat Loewenstein  2 , Dinah Zur  2
Affiliations
Review

The roadmap to geographic atrophy treatment: A journey of trials and promise

Omer Trivizki et al. Acta Ophthalmol. 2023 Dec.

Abstract

This review covers advancements in geographic atrophy (GA) research. It discusses genetic contributions to AMD, explores treatment strategies, including complement inhibition, and highlights recent FDA approvals, safety concerns and promising future directions.

PubMed Disclaimer

References

REFERENCES

    1. Banin, E., Barak, A., Boyer, D.S., Do, D.V., Ehrlich, R., Jaouni, T. et al. (2019) Phase I/IIa clinical trial of human embryonic stem cell (hESC)-derived retinal pigmented epithelium (RPE, OpRegen) transplantation in advanced dry form age-related macular degeneration (AMD): interim results. Investigative Ophthalmology & Visual Science, 60, 6402.
    1. Edmonds, R., Steffen, V., Honigberg, L.A. & Chang, M.C. (2023a) Alternative complement pathway inhibition by Lampalizumab: analysis of data from chroma and Spectri phase III clinical trials. Ophthalmology Science, 3, 100286.
    1. Edmonds, R., Steffen, V., Honigberg, L.A. & Chang, M.C. (2023b) The role of the complement pathway in clinical progression of geographic atrophy: analysis of the phase III Chroma and Spectri trials. Ophthalmology Science, 3, 100301.
    1. Gehrs, K.M., Jackson, J.R., Brown, E.N., Allikmets, R. & Hageman, G.S. (2010) Complement, age-related macular degeneration and a vision of the future. Archives of ophthalmology. Chicago, Ill. 1960, 128, 349-358.
    1. Goldberg, R., Heier, J.S., Wykoff, C.C., Staurenghi, G., Singh, R.P., Steinle, N. et al. (2022) Efficacy of intravitreal pegcetacoplan in patients with geographic atrophy (GA): 12-month results from the phase 3 OAKS and DERBY studies. Investigative Ophthalmology & Visual Science, 63, 1500.